IMA: the cashflow

MyFinsight

For the quarter ending 2025-09-30, IMA had $91,044K increase in cash & cash equivalents over the period.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30
Net loss	-38,441
Depreciation and amortization	6
Non-cash interest expense	489
Stock-based compensation expense	15,340
Accretion/amortization of premium/discount of available-for-sale securities	33
Amortization of right of use-assets	466
Gain on early extinguishment of lease liability	149
Loss on disposal of property and equipment	0
Non-cash research and development expenses for the common stock issuable pursuant to hutchmed agreement	0
Prepaid expenses and other current assets	3,574
Other non-current assets	1,277
Accounts payable	-2,179
Accrued expenses and other current liabilities	-9,945
Deferred revenue	-650
Operating lease liabilities	-694
Other long-term liabilities	15
Net cash used in operating activities	-40,626
Cash divested in non-ox40 divestiture	5,215
Proceeds from disposal of property and equipment	0
Purchases of marketable securities	1,485
Maturities and sales of marketable securities	2,250
Net cash provided by investing activities	-4,450
Proceeds from term loan	15,000
Proceeds from exercise of stock options	45
Issuance costs in connection with reverse recapitalization	-5,338
Cash acquired in connection with reverse recapitalization	-54,631
Proceeds from common stock issued in pipe financing, net of issuance costs	71,130
Net cash provided by financing activities	135,468
Effects of exchange rates on cash and cash equivalents	652
Net increase (decrease) in cash and cash equivalents	91,044
Cash and cash equivalents at beginning of period	12,118
Cash and cash equivalents at end of period	103,162

Unit: Thousand (K) dollars